Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

 

The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
publication date: Jan 3, 2014
ISSUE 1 - JAN. 3, 2014 PDF

Who Makes This Drug?
Secretive Contract Manufacturing Arrangements Complicate Solutions to Shortages of Generics

By Rena M. Conti
The closing of Ben Venue Laboratories, a company that produces a large share of generic drugs used by America’s oncologists, brings into focus a little-understood business practice that exacerbates the problem of drug shortages and shows why the industry and federal regulators have been unable to resolve them.

photo Report to the Nation: Death Rates Continue To Decline Across All Major Disease Sites

Death rates continued to decline for all cancers combined for men and women of all major racial and ethnic groups and for most major cancer sites, according to the Annual Report to the Nation on the Status of Cancer. Rates for both sexes combined decreased by 1.5 percent per year from 2001 through 2010.

photo An Appreciation: Janet Rowley, "Translational Research Pioneer"

Janet Rowley, a pioneer in connecting the development of cancer with genetic abnormalities, died from complications of ovarian cancer on Dec. 17 at her home. She was 88.

photo In Brief
  • Julie Vose Elected President of ASCO

  • 2014 Breakthrough Prize Winners Announced

  • Andrea Sloan, Prominent Ovarian Cancer Patient Dies


Copyright (c) 2016 The Cancer Letter Inc.

Letter